GPR55 and the regulation of glucose homeostasis

被引：12
作者：
Tuduri, Eva [1 ,2 ]
Lopez, Miguel [1 ,2 ,3 ]
Dieguez, Carlos [1 ,2 ,3 ]
Nadal, Angel [4 ,5 ]
Nogueiras, Ruben [1 ,2 ,3 ]
机构：
[1] Univ Santiago de Compostela, CIMUS, Inst Invest Sanitarias IDIS, Avda Barcelona S-N, Santiago De Compostela 15782, A Coruna, Spain
[2] CIBER Fisiopatol Obesidad & Nutr CIBERobn, Santiago De Compostela 15706, Spain
[3] Univ Santiago Compostela, CIMUS, Dept Physiol, Avda Barcelona S-N, Santiago De Compostela 15782, Spain
[4] Univ Miguel Hemcindez, Inst Bioingn, Elche, Spain
[5] Univ Miguel Hemcindez, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Elche, Spain
来源：
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY | 2017年 / 88卷
关键词：
Endocannabinoids; Insulin; Islets; Obesity; L-ALPHA-LYSOPHOSPHATIDYLINOSITOL; RECEPTOR GPR55; CANNABINOID RECEPTOR; POTENTIAL ROLE; ISLETS; CELLS; IDENTIFICATION; MIGRATION; RELEASE; OBESITY;
D O I：
10.1016/j.biocel.2017.04.010
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Pathophysiological conditions such as obesity and type 2 diabetes (T2D) are reportedly associated to over activation of the endocannabinoid system (ECS). Therefore, modulation of the ECS offers potential therapeutic benefits on those diseases. GPR55, the receptor for L-a-lysophosphatidylinositol (LPI) that has also affinity for various cannabinoid ligands, is distributed at the central and peripheral level and it is involved in several physiological processes. This review summarizes the localization and role of GPR55 in tissues that are crucial for the regulation of glucose metabolism, and provides an update on its contribution in obesity and insulin resistance. Finally, the therapeutic potential of targeting the GPR55 receptor is also discussed.
引用
收藏
页码：204 / 207
页数：4
相关论文
共 33 条
  • [21] Regulation, function, and dysregulation of endocannabinoids in models of adipose and β-pancreatic cells and in obesity and hyperglycemia
    Matias, Isabel
    Gonthier, Marie-Paule
    Orlando, Pierangelo
    Martiadis, Vassilis
    De Petrocellis, Luciano
    Cervino, Cristina
    Petrosino, Stefania
    Hoareau, Laurence
    Festy, Franck
    Pasquali, Renato
    Roche, Regis
    Maj, Mario
    Pagotto, Uberto
    Monteleone, Palmiero
    Di Marzo, Vincenzo
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (08) : 3171 - 3180
  • [22] Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice
    McKillop, A. M.
    Moran, B. M.
    Abdel-Wahab, Y. H. A.
    Flatt, P. R.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2013, 170 (05) : 978 - 990
  • [23] Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice
    McKillop, Aine M.
    Moran, Brian M.
    Abdel-Wahab, Yasser H. A.
    Gormley, Noella M.
    Flatt, Peter R.
    [J]. DIABETOLOGIA, 2016, 59 (12) : 2674 - 2685
  • [24] Deletion of G-protein-coupled receptor 55 promotes obesity by reducing physical activity
    Meadows, A.
    Lee, J. H.
    Wu, C-S
    Wei, Q.
    Pradhan, G.
    Yafi, M.
    Lu, H-C
    Sun, Y.
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2016, 40 (03) : 417 - 424
  • [25] LYSOPHOSPHATIDYLINOSITOL, BUT NOT LYSOPHOSPHATIDIC ACID, STIMULATES INSULIN RELEASE - A POSSIBLE ROLE FOR PHOSPHOLIPASE-A2 BUT NOT DENOVO SYNTHESIS OF LYSOPHOSPHOLIPID IN PANCREATIC-ISLET FUNCTION
    METZ, SA
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 138 (02) : 720 - 727
  • [26] Identification of GPR55 as a lysophosphatidylinositol receptor
    Oka, Saori
    Nakajima, Keisuke
    Yamashita, Atsushi
    Kishimoto, Seishi
    Sugiura, Takayuki
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 362 (04) : 928 - 934
  • [27] A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans
    Romero-Zerbo, Silvana Y.
    Rafacho, Alex
    Diaz-Arteaga, Adenis
    Suarez, Juan
    Quesada, Ivan
    Imbernon, Monica
    Ross, Ruth A.
    Dieguez, Carlos
    Rodriguez de Fonseca, Fernando
    Nogueiras, Ruben
    Nadal, Angel
    Bermudez-Silva, Francisco J.
    [J]. JOURNAL OF ENDOCRINOLOGY, 2011, 211 (02) : 177 - 185
  • [28] The orphan receptor GPR55 is a novel cannabinoid receptor
    Ryberg, E.
    Larsson, N.
    Sjoegren, S.
    Hjorth, S.
    Hermansson, N-O
    Leonova, J.
    Elebring, T.
    Nilsson, K.
    Drmota, T.
    Geasley, P. J.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2007, 152 (07) : 1092 - 1101
  • [29] Identification and cloning of three novel human G protein-coupled receptor genes GPR52, ΨGPR53 and GPR55:: GPR55 is extensively expressed in human brain
    Sawzdargo, M
    Nguyen, T
    Lee, DK
    Lynch, KR
    Cheng, R
    Heng, HHQ
    George, SR
    O'Dowd, BF
    [J]. MOLECULAR BRAIN RESEARCH, 1999, 64 (02): : 193 - 198
  • [30] A potential role for GPR55 in the regulation of energy homeostasis
    Simcocks, Anna C.
    O'Keefe, Lannie
    Jenkin, Kayte A.
    Mathai, Michael L.
    Hryciw, Deanne H.
    McAinch, Andrew J.
    [J]. DRUG DISCOVERY TODAY, 2014, 19 (08) : 1145 - 1151
1234